Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial

The Lancet Haematology

Volumn 3, Issue 9, 2016, Pages e415-e425

  Khalafallah, Alhossain A ^a,b,c   Yan, Carl ^a   Al Badri, Raghad ^a   Robinson, Ella ^a   Kirkby, Brooke E ^a   Ingram, Emily ^a   Gray, Zara ^a   Khelgi, Vinod ^a   Robertson, Iain K ^c   Kirkby, Brian P ^a,d  

^a LAUNCESTON GENERAL HOSPITAL   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d Calvary Health Care   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRIC ION; HEMOGLOBIN; MALTOSE;

ADULT; ANEMIA; ARTICLE; BLOOD CULTURE; BLOOD TRANSFUSION; EVALUATION AND FOLLOW UP; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE ASSESSMENT; REGRESSION ANALYSIS; YOUNG ADULT; AGED; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; CONTROLLED STUDY; ELECTIVE SURGERY; FOLLOW UP; HEALTH CARE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INTRAVENOUS; AGED; ANEMIA, IRON-DEFICIENCY; ELECTIVE SURGICAL PROCEDURES; FEMALE; FERRIC COMPOUNDS; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; MALE; MALTOSE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STANDARD OF CARE;

EID: 84991699790     PISSN: None     EISSN: 23523026     Source Type: Journal    
DOI: 10.1016/S2352-3026(16)30078-3     Document Type: Article

References (35)

1. 1 Pasricha, SR, Flecknoe-Brown, SC, Allen, KJ, et al. Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust 193 (2010), 525–532.
2. 2 WHO. Nutritional anaemias. Report of a WHO scientific group, 1968, World Health Organization, Geneva.
3. 3 Guralnik, JM, Eisenstaedt, RS, Ferrucci, L, Klein, HG, Woodman, RC, Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104 (2004), 2263–2268.
4. 4 Bisbe Vives, E, Molto, L, Therapeutic approach to postoperative anemia. Rev Esp Anestesiol Reanim 62:suppl 1 (2015), 41–44.
5. 5 Clevenger, B, Richards, T, Pre-operative anaemia. Anaesthesia 70:suppl 1 (2015), 20–28.
6. 6 Kotzé, A, Harris, A, Baker, C, et al. British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia. Br J Haematol 171 (2015), 322–331.
7. 7 National Blood Authority, Australia. Patient blood management guidelines: module 2—perioperative. 2012. www.nba.gov.au/guidelines/module2/index.html (accessed May 2, 2016).
8. 8 Padhi, S, Kemmis-Betty, S, Rajesh, S, Hill, J, Murphy, MF, Blood transfusion: summary of NICE guidance. BMJ, 351, 2015, h5832.
9. 9 Parker, MJ, Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. J Bone Joint Surg Am 92 (2010), 265–269.
10. 10 Mundy, GM, Birthwistle, SJ, Power, RA, The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty. J Bone Joint Surg Br 87 (2005), 213–217.
11. 11 Beris, P, Munoz, M, Garcia-Erce, JA, Thomas, D, Maniatis, A, Van der Linden, P, Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 100 (2008), 599–604.
12. 12 Goodnough, LT, Maniatis, A, Earnshaw, P, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 106 (2011), 13–22.
13. 13 Muñoz, M, Gómez-Ramírez, S, Cuenca, J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 54 (2014), 289–299.
14. 14 Spahn, DR, Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 113 (2010), 482–495.
15. 15 Bisbe, E, Molto, L, Arroyo, R, Muniesa, JM, Tejero, M, Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. Br J Anaesth 113 (2014), 402–409.
16. 16 Muñoz, M, Naveira, E, Seara, J, Cordero, J, Martos, F, Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. Br J Anaesth 108 (2012), 532–534.
17. 17 Karkouti, K, McCluskey, SA, Ghannam, M, Salpeter, MJ, Quirt, I, Yau, TM, Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 53 (2006), 11–19.
18. 18 Andrews, CM, Lane, DW, Bradley, JG, Iron pre-load for major joint replacement. Transfus Med 7 (1997), 281–286.
19. 19 Knovich, MA, Storey, JA, Coffman, LG, Torti, SV, Torti, FM, Ferritin for the clinician. Blood Rev 23 (2009), 95–104.
20. 20 Wallis, JP, Wells, AW, Whitehead, S, Brewster, N, Recovery from post-operative anaemia. Transfus Med 15 (2005), 413–418.
21. 21 Goddard, AF, James, MW, McIntyre, AS, Scott, BB, Guidelines for the management of iron deficiency anaemia. Gut 60 (2011), 1309–1316.
22. 22 Zager, RA, Johnson, ACM, Hanson, SY, Parenteral iron therapy exacerbates experimental sepsis. Kidney Int 65 (2004), 2108–2112.
23. 23 Macdougall, IC, Bock, AH, Carrera, F, et al. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant 29 (2014), 2075–2084.
24. 24 Muñoz, M, García-Erce, JA, Cuenca, J, Bisbe, E, Naveira, E, On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery. Blood Transfus 10 (2012), 8–22.
25. 25 Khalafallah, A, Dennis, A, Bates, J, et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 268 (2010), 286–295.
26. 26 Khalafallah, AA, Dennis, AE, Ogden, K, et al. Three-year follow-up of a randomised clinical trial of intravenous versus oral iron for anaemia in pregnancy. BMJ Open, 2, 2012 PII:e000998.
27. 27 Aapro, M, Osterborg, A, Gascon, P, Ludwig, H, Beguin, Y, Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol 23 (2012), 1954–1962.
28. 28 Hansen, TM, Hansen, NE, Serum ferritin as indicator of iron responsive anaemia in patients with rheumatoid arthritis. Ann Rheum Dis 45 (1986), 596–602.
29. 29 Punnonen, K, Irjala, K, Rajamaki, A, Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89 (1997), 1052–1057.
30. 30 Auerbach, M, Ballard, H, Glaspy, J, Clinical update: intravenous iron for anaemia. Lancet 369 (2007), 1502–1504.
31. 31 Larson, DR, Coyne, DW, Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease. Kidney Res Clin Pract 32 (2013), 11–15.
32. 32 Breymann, C, Zimmermann, R, Huch, R, Huch, A, Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia. Eur J Clin Invest 26 (1996), 123–130.
33. 33 Khalafallah, AA, Chilvers, CR, Thomas, M, et al. Usefulness of non-invasive spectrophotometric Hb estimation for detecting low haemoglobin levels when compared with a standard laboratory assay for preoperative assessment. Br J Anaesth 114 (2015), 669–676.
34. 34 Spahn, DR, Goodnough, LT, Alternatives to blood transfusion. Lancet 381 (2013), 1855–1865.
35. 35 Auerbach, M, Intravenous iron in the perioperative setting. Am J Hematol, 89, 2014, 933.